Singer Capital Markets Securities Ltd, an exempt principal trader, disclosed dealings in relevant securities of HIPGNOSIS SONGS FUND LTD on 5th June 2024. The disclosed dealings included both purchases and sales of ORD NVP securities, with the highest price per unit paid at 101.54p and the lowest at 101.04p. The disclosure also confirmed that there were no indemnity or other dealing arrangements, agreements, arrangements, or understandings relating to options or derivatives.

The disclosure, made under Rule 8 of the Takeover Code, is a requirement for exempt principal traders with recognized intermediary status dealing in a client-serving capacity. The information provided in the disclosure is essential for transparency and regulatory compliance. It ensures that all relevant parties are informed about the dealings and any potential inducements to deal or refrain from dealing.

This public disclosure is an important part of the regulatory framework, providing transparency and insight into the trading activities related to HIPGNOSIS SONGS FUND LTD. It allows investors and other interested parties to understand the recent dealings in relevant securities and any associated agreements or arrangements. The disclosure also serves to uphold the integrity of the market by ensuring that all relevant information is made available to the public in a timely manner.

The disclosure was made to a Regulatory Information Service, as required by Rule 8 of the Code, and is an important aspect of maintaining market integrity. It provides a clear overview of the dealings undertaken by Singer Capital Markets Securities Ltd in relation to HIPGNOSIS SONGS FUND LTD, contributing to a transparent and well-regulated market environment.